||Costas G. Hadjipanayis, MD, PhD
Mount Sinai Health System/Icahn School of Medicine at Mount Sinai, 10 Union Square East, Suite 5E, Department of Neurosurgery, New York, NY 10003
||United States of America
Dr. Hadjipanayis is a Professor of Neurosurgery and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. He serves as Chair of the Department of Neurosurgery at Mount Sinai Union Square/Beth Israel and Director of Neurosurgical Oncology for the Mount Sinai Health System in New York City. He joined Mount Sinai in 2015 from Emory University where he was an Associate Professor and served as the inaugural Director of the Emory Brain Tumor Center at the Winship Cancer Institute and Chief of Neurosurgery at Emory University Hospital Midtown. In 2006, Dr. Hadjipanayis completed his neurosurgical training at the University of Pittsburgh Medical Center under the mentorship of Dr. L. Dade Lunsford. During his residency, he was able to secure NIH funding (T32) that led to the successful completion of a doctorate (Ph.D.) in Molecular Genetics and Biochemistry with Dr. Neal DeLuca at the University of Pittsburgh focused on viral gene therapy of glioblastoma.
Dr. Hadjipanayis has continued his work as a neurosurgeon-scientist focusing on novel translational treatments of brain tumors and obtaining further NIH funding with K08, R01, and R21 grants. The Brain Tumor Nanotechnology Laboratory he directs has mentored a number of students and neurosurgery residents. His lab has also received multiple private foundation grants, including from the Dana Foundation and the American Brain Tumor Association. Dr. Hadjipanayis is a permanent NIH study section member with the Radiation Therapeutics and Biology (RTB) group and serves on the editorial boards of the Journal of Neuro-Oncology and Cancer Nanotechnology. Dr. Hadjipanayis has been quite involved with educational initiatives in organized neurosurgery with the AANS, CNS, NREF, and the SNS. He has also served as the President of the Georgia Neurosurgery Society.
Currently, he serves as Chair of Education for the AANS/CNS Executive Committee for the Section on Tumors. While at Emory, he was able to organize and lead the SNS Southeast Neurosurgery Intern Bootcamp with Dr. Daniel Barrow before moving to New York. He just received approval to direct and host the SNS PGY-2 Bootcamp at Mount Sinai in 2020. Dr. Hadjipanayis has been a tireless brain tumor advocate leading the nonprofit Southeastern Brain Tumor Foundation as President. He has been the PI of multiple clinical trials focused on gliomas including the Sponsor and IND holder of a multicenter Phase II study involving the use of 5-ALA (Gliolan) and fluorescence-guided surgery (FGS) for the resection of high-grade gliomas. He was the first to use Gliolan and perform FGS on a glioma patient in the US in 2011. One of his most notable accomplishments was leading the FDA approval in the US of 5-ALA (Gleolan) for glioma surgery in June of 2017.
He has formally trained neurosurgeons on the use of 5-ALA FGS with live surgeries, instructional lectures, and symposia. He recently edited the first textbook with Dr. Walter Stummer entitled "Fluorescence-Guided Neurosurgery: Neuro-oncology and Cerebrovascular Applications". Costas and his wife, Lorraine, enjoy traveling with their 3 children, Panikos, Athena, and Elias, to Greece and Cyprus in the summer. His children are actively involved with softball, crew, and sailing.